Table of Contents
Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
Chapter 3. Autism Spectrum Disorder Market: By Disorder Type Trends, Size, and Future Outlook
- By Disorder Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Disorder Type Definitions, Technology Landscape
- By Disorder Type Market Drivers
- Product Launches
- Technology Launches
- By Disorder Type Market Restraints
Chapter 4. Autism Spectrum Disorder Market: By Treatment Type Trends, Size, and Future Outlook
- By Treatment Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Treatment Type Definitions, Technology Landscape
- By Treatment Type Market Drivers
- Product Launches
- Technology Launches
- By Treatment Type Market Restraints
Chapter 5. Autism Spectrum Disorder Market: By End-User Trends, Size, and Future Outlook
- By End-User Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By End-User Definitions, Technology Landscape
- By End-User Market Drivers
- Product Launches
- Technology Launches
- By End-User Market Restraints
Chapter 6. Autism Spectrum Disorder Market: By Age Group Trends, Size, and Future Outlook
- By Age Group Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Age Group Definitions, Technology Landscape
- By Age Group Market Drivers
- Product Launches
- Technology Launches
- By Age Group Market Restraints
Chapter 7. Autism Spectrum Disorder Market: By Distribution Channel Trends, Size, and Future Outlook
- By Distribution Channel Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Distribution Channel Definitions, Technology Landscape
- By Distribution Channel Market Drivers
- Product Launches
- Technology Launches
- By Distribution Channel Market Restraints
Chapter 8. Autism Spectrum Disorder Market: By Product Type Trends, Size, and Future Outlook
- By Product Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Product Type Definitions, Technology Landscape
- By Product Type Market Drivers
- Product Launches
- Technology Launches
- By Product Type Market Restraints
Chapter 9. Autism Spectrum Disorder Market: Regional Market Trends, Size, and Future Outlook
- North America Trends, Market Size (US$), CAGR (%), and Future Outlook
- North America Market Size (US$), CAGR (%), and Forecast (2021-2031)
- North America Definitions, Technology Landscape
- North America Market Drivers
- Product Launches
- Technology Launches
- North America Market Restraints
- Competitive Outlook
- Europe Trends, Market Size (US$), CAGR (%), and Future Outlook
- Europe Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Europe Definitions, Technology Landscape
- Europe Market Drivers
- Product Launches
- Technology Launches
- Europe Market Restraints
- Competitive Outlook
- Asia Pacific Trends, Market Size (US$), CAGR (%), and Future Outlook
- Asia Pacific Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Asia Pacific Definitions, Technology Landscape
- Asia Pacific Market Drivers
- Product Launches
- Technology Launches
- Asia Pacific Market Restraints
- Competitive Outlook
- Latin America Trends, Market Size (US$), CAGR (%), and Future Outlook
- Latin America Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Latin America Definitions, Technology Landscape
- Latin America Market Drivers
- Product Launches
- Technology Launches
- Latin America Market Restraints
- Competitive Outlook
- Middle East & Africa Trends, Market Size (US$), CAGR (%), and Future Outlook
- Middle East & Africa Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Middle East & Africa Definitions, Technology Landscape
- Middle East & Africa Market Drivers
- Product Launches
- Technology Launches
- Middle East & Africa Market Restraints
- Competitive Outlook
Chapter 10. Autism Spectrum Disorder Market: Competitive Landscape
- Roche
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Novartis
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Pfizer
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Johnson & Johnson
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- GlaxoSmithKline
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Merck & Co.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Sanofi
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- AstraZeneca
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Eli Lilly and Company
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bristol-Myers Squibb
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Otsuka Pharmaceutical Co., Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Curemark
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Consern Pharma
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- NeuroNascent
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Alcobra Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Neuropharm
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Confluence Pharmaceuticals
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Yamo Pharmaceuticals
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Neurotrope
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Vanda Pharmaceuticals
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The Autism Spectrum Disorder Market had an estimated market size worth US$ 6.2 billion in 2023.
Rising prevalence of ASD, increasing awareness and screening, government support and funding, demand for effective therapies, advancements in diagnostics and treatment, growing healthcare expenditure, and increasing research and development efforts.
High treatment costs, lack of trained professionals, social stigma and misconceptions, regulatory challenges for approvals, limited access to care in some regions, and the complexity of the disorder.
The autistic disorder segment is the leading component segment in the Autism Spectrum Disorder Market, as it encompasses the most common form of ASD.
Roche, Novartis, Pfizer, Johnson & Johnson, GlaxoSmithKline, Merck & Co., Sanofi, AstraZeneca, Eli Lilly and Company, Bristol-Myers Squibb, Otsuka Pharmaceutical Co., Ltd., Curemark, Consern Pharma, NeuroNascent, Alcobra Ltd., Neuropharm, Confluence Pharmaceuticals, Yamo Pharmaceuticals, Neurotrope, and Vanda Pharmaceuticals.
Autism Spectrum Disorder Market Expected to Achieve US$ 15.7 Bn by 2031 exhibiting a robust CAGR 12.3% during the forecast period.
The key drivers of the Autism Spectrum Disorder Market include rising prevalence of ASD, increasing awareness and screening, government support and funding, demand for effective therapies, advancements in diagnostics and treatment, and growing healthcare expenditure.